# Filing Signal Summary: ELV

### Stock Movement Analysis for ELV

#### Key Material Disclosures:

- **Earnings Announcement:**
  - Elevance Health, Inc. anticipates reporting first quarter 2025 GAAP shareholders' net income of $9.61 per diluted share, with adjusted net income at $11.97 per diluted share.
  - The company has reaffirmed its full-year 2025 adjusted net income guidance in the range of $34.15 to $34.85 per diluted share.

- **Operational Highlights:**
  - First quarter results align with projected medical cost trends, especially within the Medicare Advantage segment.
  - Elevance Health expects its full-year 2025 Medicare Advantage membership to range between 2,200 to 2,250 thousand members.

- **Future Outlook:**
  - Additional details on the first quarter financial results and the full-year outlook will be disclosed on April 22, 2025.

#### Investor Concerns:
The disclosed information indicates a stable financial performance and operational outlook for Elevance Health, Inc., potentially reassuring investors about the company's trajectory. However, investors may closely monitor the upcoming detailed financial results and outlook release for any deviations or risks that could impact the stock price.

This summary highlights the company's financial performance, operational trends, and reaffirmed guidance, which could have influenced the observed stock price change of -2.36% on April 21, 2025.

## ðŸ“Š Market Reaction
The stock is currently trading at $424.78 as of 2025-04-21 01:28:38, a change of -2.36% from the previous sessionâ€™s close.

[ðŸ”— View 8-K Filing on SEC.gov](https://www.sec.gov/Archives/edgar/data/1156039/0001156039-25-000051-index.html)